Adil Khan
My professional endeavors over the past two decades have been to help organizations breakthrough the mundane and lay the groundwork for their transformation. My experiences range from Academic research into cracking nature’s code of deadly pathogens to Containment of deadly outbreaks in the Public Health space to presently as Global Head of Marketing for Dermatology at Boehringer Ingelheim bringing breakthroughs to patients who suffer from rare diseases. I hold a Doctorate in Infectious Diseases from McMaster University, a Masters in Laboratory Medicine and an MBA in Global Healthcare from the University of Toronto.
Thursday 23 May
Go To Market Approaches in Rare Diseases: The Role of Omni - Channel Marketing
Rare disease solutions represent a growing percentage of pharmaceutical innovation. The unmet need for these patients is significant but the challenge lies in finding these patients and bringing life-saving drugs to them. But how to do this when large field forces are not affordable?
Omni–channel marketing not only provides an alternative path but rather the first-line approach toward Go To Market.
Adil Khan
Global Head of Dermatology Marketing
Boehringer Ingelheim
